The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Tells anyone its a bargain http://www.bloomberg.com/quote/MBIBAAU:ID/chart
Nice big £27k buy soaked up all the PI sells.
Wow we have some big volume
yes that was the question from Malcolm Edwards
Twitter Jim Mellon It was the question 5h ago from MalcolmJEdwards regarding PEBI I wanted to know the question of?
Twitter Jim Mellon It was the question 5h ago from MalcolmJEdwards regarding PEBI I wanted to know the question of?
Thanks for that
Mr Mellon asked if his focus / interest moving from bio to robotics i guess because of his new book. he answered no
Jim Mellon just mentioned PEBI on twitter, what was the question please as I'm not a member?
but what is the link between PEBI and PLE and SUMM? SUMM is a share I was tracking until yesterday's huge placing at a huge discount with no explanation, which I thought was criminal! If PEBI is too strongly linked with those shares then would it be fair to suggest the share price deserves to fall here?
Well done buyers this morning Magna fund on the up PEBI down is good for a bargain, we are increasing Magna exposure so maybe less exposed to SUMM than last update!
True, but both PLE and SUMM are taking somewhat of a pounding. This shouldn't track directly, but there is obviously a substantial carry over to this SP. Still see this as a great opportunity.
This is an opportunity, just had a £500 top up, because we track SUMM and PLE although Magna was over 55% of PF and growing last update people reacting to SUMM news which is less than 25% of our NAV.
Last update we received suggested PEBI have reduced their SUMM holding although we are still exposed. On another point, great to see LSE have gone mobile, much easier trawling through posts
Sp getting hammered, no one likes a paper loss. I loaded up between 11-13p but wish I was loading up now.
The NAV is important here not the sp, that is why in Nov there is the option for cash or to join Magna at NAV as Jim Mellon isn't happy with the sp discount to NAV. Read the RNS, yes it's dropping but PLE, SUMM and the Magna fund are stable or rising slightly.
I know you are very positive about this share but there is the old saying 'when things seem too good to be true they usually are', i'm not trying to deramp here as I am still invested, but you have mentioned many times that its a great opportunity to buy or top up and its a no brainer, yet the share price continues to go down.
I thinkmyour observation is correct, I think it tracks PLE mainly for some reason, personally I hope they sell all PLE and SUMM at a decent price and pile it into Magna as the are divi paying US stocks with much much lower risk. With regards to Mr Lee, I actually think his recent sales have been some quite clever profit taking as he loaded up at good prices and probably sold when we were at circa 15-16p so who can blame him, I personally don't think he'd sell at these levels, I think the seller now are PI's who don't want to wait to Nov so are chasing the big rise dream on AIM - personally a very low risk share which is 50% under NAV with a NAV cash option in 9 months to me is a dream.
I feel it trends too closely (disproportionately so) with SUMM and PLE. It's advantageous for us all really though, as disconnect widens it becomes an increasingly good investment. No rush though, as I suspect Mr Lee is still selling.
Magna fund performing well, PEBI falling - biggest no brainer on AIM http://www.bloomberg.com/quote/MBIBAAU:ID
All is my interpretation
Is cash for the magna biopharma income fund investments or all of PEBI investments
Option to take cash at NAV value, currently 15.9p (last update)
sorry why is November significant?